About Memory-Touch
Product Information
Molecule Name
Rivastigmine
Available Strengths
9mg (4.6mg of drug is released in 24hrs) transdermal patches
18mg (9.5mg of drug is released in 24hrs) transdermal patches
Dosing Schedule
One patch every 24 hours
Indication
Memory Touch (Rivastigmine Transdermal Patch) is indicated for the treatment of patients with mild to moderately severe dementia of the Alzheimer type and dementia associated with Parkinson’s disease.
Want to Learn More?
We're here to help you find the best solution for your needs. Contact us today!
Get in Touch